ET Now Exclusive - Biocon downplays Statin fears
Biocon Up 0.21%. Insulin sales string in emerging markets.
Developing glargine for global markets currently. India capacity to double.
Branded formulations may grow 50% this year.

Join us for the latest developments in Business World on Google+.
Click here and "Add to Circles" http://bit.ly/ETNOWonGooglePlus

Join #ETNOW on Linkedin to understand, discuss latest business news and development,
Click here and join the group http://linkd.in/ETNOWonLinkedin

Surscribe to www.youtube.com/etnow to get latest business news, analysis and updates.
OR
Follow us on www.dailymotion.com/etnow to get latest video updates

Like the ET Now facebook page on http://www.facebook.com/etnow
and
To get the latest market and business news follow us on twitter @etnowlive